tradingkey.logo

Helius Medical Technologies Inc

HSDT
查看詳細走勢圖
2.780USD
-0.050-1.77%
收盤 12/26, 16:00美東報價延遲15分鐘
112.03M總市值
虧損本益比TTM

Helius Medical Technologies Inc

2.780
-0.050-1.77%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.77%

5天

-6.71%

1月

-30.67%

6月

-83.64%

今年開始到現在

-99.45%

1年

-99.54%

查看詳細走勢圖

操作建議

Helius Medical Technologies Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名139/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價0.00。中期看,股價處於下降通道。近一個月,市場表現非常差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Helius Medical Technologies Inc評分

相關信息

行業排名
139 / 207
全市場排名
371 / 4563
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 1 分析師
持有
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Helius Medical Technologies Inc亮點

亮點風險
Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
業績增長期
公司處於發展階段,最新年度總收入520.00K美元
估值合理
公司最新PE估值0.00,處於3年歷史合理位
機構加倉
最新機構持股3.90M股,環比增加49.99%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉0.00股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.99

Helius Medical Technologies Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Helius Medical Technologies Inc簡介

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
公司代碼HSDT
公司Helius Medical Technologies Inc
CEOAndreeff (Dane C)
網址https://heliusmedical.com/

常見問題

Helius Medical Technologies Inc(HSDT)的當前股價是多少?

Helius Medical Technologies Inc(HSDT)的當前股價是 2.780。

Helius Medical Technologies Inc 的股票代碼是什麼?

Helius Medical Technologies Inc的股票代碼是HSDT。

Helius Medical Technologies Inc股票的52週最高點是多少?

Helius Medical Technologies Inc股票的52週最高點是1200.000。

Helius Medical Technologies Inc股票的52週最低點是多少?

Helius Medical Technologies Inc股票的52週最低點是2.620。

Helius Medical Technologies Inc的市值是多少?

Helius Medical Technologies Inc的市值是112.03M。

Helius Medical Technologies Inc的淨利潤是多少?

Helius Medical Technologies Inc的淨利潤為-11.74M。

現在Helius Medical Technologies Inc(HSDT)的股票是買入、持有還是賣出?

根據分析師評級,Helius Medical Technologies Inc(HSDT)的總體評級為持有,目標價格為--。

Helius Medical Technologies Inc(HSDT)股票的每股收益(EPS TTM)是多少

Helius Medical Technologies Inc(HSDT)股票的每股收益(EPS TTM)是-860.677。
KeyAI